FDA Announces Draft Guidance for Portable Invasive Blood Glucose Monitoring Systems

Summary

The Food and Drug Administration (FDA) has released a draft guidance document outlining its recommendations for portable invasive blood glucose monitoring systems, which will help industry and FDA staff navigate the product life cycle for these devices.